|
| |
Salmedix San DIego Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
BioPortfolio - salmedix
Palmer joins Kosan from Salmedix in San Diego, where he was medical director for ... Salmedix, Inc. is a San Diego-based biopharmaceutical company formed to ...
http://www.bioportfolio.com/search/salmedix.html...
|
BioSpace - Salmedix, Inc. News, Search Jobs, Events
19 Oct 2005 ... Salmedix, Inc. 9380 Judicial Drive San Diego California 92121 U.S.A. ... Salmedix, Inc. Presents Preclinical Data For Treanda And Other ...
http://www.biospace.com/company_profile.aspx?CompanyID=47321...
|
Salmedix, Inc. Company Profile - Yahoo! Finance
Capsule info for Salmedix, Inc. ... Contact Information. Address: 9381 Judicial Dr., Ste. 160 San Diego, CA 92121. Phone: 858-622-5050. Fax: 858-622-5060 ...
http://biz.yahoo.com/ic/132/132701.html...
|
BioPortfolio - Biocorporate Search San Diego
Salmedix, Inc. is a San Diego-based biopharmaceutical company formed to in- license, develop and commercialize new cancer drugs, with an initial focus on
...
http://www.bioportfolio.com/biocorporate/search/city/San+Die...
|
{1} Presents Preclinical Data On Product Candidates At The {2 ...
SAN DIEGO, March 25 /PRNewswire/ -- Salmedix, Inc. announced today that company scientists and independent researchers will be presenting data supporting ...
http://www.biospace.com/news_story.aspx?NewsEntityId=1554652...
|
R-ETODOLAC DECREASES BETA-CATENIN LEVELS ALONG WITH SURVIVAL AND ...
R-Etodolac (Salmedix, San Diego, CA) was dissolved in sterile DMSO at 250mM immediately before use. Final concentrations of R-Etodolac ranged from 100 to
...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=19...
|
{1} Announces The Appointment Of Pratik Multani, MD, MS, As ...
SAN DIEGO, March 9 /PRNewswire/ -- Salmedix, Inc. announced today that it has appointed oncologist Pratik S. Multani, MD, MS, to the newly created position
...
http://www.biospace.com/news_story.aspx?NewsEntityId=1540282...
|
SDX-101, the R-enantiomer of etodolac, induces cytotoxicity ...
R-etodolac (SDX-101) is currently being tested (Salmedix, San Diego, CA) in phase 2 clinical trials for treatment of refractory CLL. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=18...
|
Modern Pathology - Concordant loss of MTAP and p16//CDKN2A ...
g/ml of the monoclonal antihuman MTAP antibody (Clone 6.9, Salmedix, Inc., San Diego, CA, USA). Incubation of labeled polymer (Dako, Envision Plus Detection
...
http://www.nature.com/modpathol/journal/v18/n7/full/3800377a...
|
{1} Announces Acquisition Of {2}; Approximately $160 Million Cash ...
Founded in 2000, Salmedix, Inc. is a privately-held oncology drug development company based in San Diego, California. Salmedix is primarily focused on ...
http://www.biospace.com/news_story.aspx?NewsEntityId=2005242...
|
|
